Skip to content
ppharmaranks
Menu

Best treatments for substance withdrawal syndrome

3 products may treat substance withdrawal syndrome, spanning FDA drug classes such as typical antipsychotic, antihistamine. The current highest-rated option is haloperidol. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 3 drugs we list for substance withdrawal syndrome, all are available as lower-cost generics, spanning classes such as typical antipsychotic, antihistamine. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for substance withdrawal syndrome — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate
Treatments we list for substance withdrawal syndrome
#DrugRatingPharmacy pays
168/100$5View →
2Not yet rated$0View →
3Not yet rated$288View →

Full ranking · 3 treatments

Frequently asked

What treats substance withdrawal syndrome?
Our catalog lists 3 products that may treat substance withdrawal syndrome, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is haloperidol.
What is the best-rated treatment for substance withdrawal syndrome?
By our independent recall-safety rating — not an efficacy measure — haloperidol ranks highest among the products we list for substance withdrawal syndrome. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat substance withdrawal syndrome?
Treatments for substance withdrawal syndrome span FDA drug classes including typical antipsychotic, antihistamine. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.